Sign In
Buy CBAY
$32.48
+0 (+0%)
At Close: Apr 11, 2024
CymaBay Rose 127% on Positive NASH Trial Update - Market Realist
11:35am, Wednesday, 13'th May 2020
On Tuesday, CymaBay Therapeutics (NASDAQ:CBAY) stock rose 127.2% after the company highlighted a positive NASH trial update.
B. Riley FBR Upgrades CymaBay Therapeutics to Buy, Raises Price Target of $6
10:52am, Wednesday, 13'th May 2020Edited Transcript of CBAY earnings conference call or presentation 11-May-20 8:30pm GMT
07:20pm, Tuesday, 12'th May 2020
Q1 2020 Cymabay Therapeutics Inc Earnings Call
Mid-Afternoon Market Update: Dow Falls 150 Points; Eventbrite Shares Tumble On Downbeat Q1 Results
06:35pm, Tuesday, 12'th May 2020Mid-Day Market Update: Crude Oil Rises Over 7%; Genfit Shares Plummet
04:39pm, Tuesday, 12'th May 2020A Look Into CymaBay Therapeutics Price Over Earnings
02:34pm, Tuesday, 12'th May 2020
Looking into the current session, CymaBay Therapeutics Inc. (NASDAQ: CBAY) shares are trading at $4.21, after a 129% spike. Moreover, over the past month, the stock increased by 138.41%, but in the pa
CymaBay Therapeutics' stock more than doubles amid hopes FDA will lift hold on NASH treatment
01:45pm, Tuesday, 12'th May 2020
Shares of CymaBay Therapeutics Inc. undefined rocketed on in very active morning trading Tuesday, after an upbeat report on results of a study of its...
CymaBay Therapeutics' stock more than doubles amid hopes FDA will lift hold on NASH treatment
01:45pm, Tuesday, 12'th May 2020
Shares of CymaBay Therapeutics Inc. rocketed on in very active morning trading Tuesday, after an upbeat report on results of a study of its treatment of liver disease prompted a wave of upgrades by W
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) * Acceleron Pharma Inc (NASDAQ: XLRN) * Akebia Therap
